• This record comes from PubMed

The COORDINATE Pilot Study: Impact of a Transcatheter Aortic Valve Coordinator Program on Hospital and Patient Outcomes

. 2022 Feb 23 ; 11 (5) : . [epub] 20220223

Status PubMed-not-MEDLINE Language English Country Switzerland Media electronic

Document type Journal Article

Grant support
N/A Edwards Lifesciences (Switzerland)

The transcatheter aortic valve implantation (TAVI) treatment pathway is complex, leading to procedure-related delays. Dedicated TAVI coordinators can improve pathway efficiency. COORDINATE was a pilot observational prospective registry at three German centers that enrolled consecutive elective patients with severe aortic stenosis undergoing TAVI to investigate the impact a TAVI coordinator program. Pathway parameters and clinical outcomes were assessed before (control group) and after TAVI coordinator program implementation (intervention phase). The number of repeated diagnostics remained unchanged after implementation. Patients with separate hospitalizations for screening and TAVI had long delays, which increased after implementation (65 days pre- vs. 103 days post-implementation); hospitalizations combining these were more efficient. The mean time between TAVI and hospital discharge remained constant. Nurse (p = 0.001) and medical technician (p = 0.008) working hours decreased. Patient satisfaction increased, and more consistent/intensive contact between patients and staff was reported. TAVI coordinators provided more post-TAVI support, including discharge management. No adverse effects on post-procedure or 30-day outcomes were seen. This pilot suggests that TAVI coordinator programs may improve aspects of the TAVI pathway, including post-TAVI care and patient satisfaction, without compromising safety. These findings will be further investigated in the BENCHMARK registry.

See more in PubMed

Baumgartner H., Falk V., Bax J.J., De Bonis M., Hamm C., Holm P.J., Iung B., Lancellotti P., Lansac E., Rodriguez Munoz D., et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J. 2017;38:2739–2791. doi: 10.1093/eurheartj/ehx391. PubMed DOI

Mack M.J., Leon M.B., Thourani V.H., Makkar R., Kodali S.K., Russo M., Kapadia S.R., Malaisrie S.C., Cohen D.J., Pibarot P., et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N. Engl. J. Med. 2019;380:1695–1705. doi: 10.1056/NEJMoa1814052. PubMed DOI

Popma J.J., Deeb G.M., Yakubov S.J., Mumtaz M., Gada H., O’Hair D., Bajwa T., Heiser J.C., Merhi W., Kleiman N.S., et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N. Engl. J. Med. 2019;380:1706–1715. doi: 10.1056/NEJMoa1816885. PubMed DOI

Lauck S., Achtem L., Boone R.H., Cheung A., Lawlor C., Ye J., Wood D.A., Webb J.G. Implementation of processes of care to support transcatheter aortic valve replacement programs. Eur. J. Cardiovasc. Nurs. 2013;12:33–38. doi: 10.1016/j.ejcnurse.2011.06.005. PubMed DOI

Gemeinsamer Bundesausschuss Richtlinie über Maßnahmen zur Qualitätssicherung bei der Durchführung von Minimalinvasiven Herzklappeninterventionen Gemäß § 137 Absatz 1 Satz 1 Nummer 2 für nach § 108 SGB V Zugelassene Krankenhäuser (Richtlinie zu Minimalinvasiven Herzklappenintervention/MHI-RL) 2015. [(accessed on 2 February 2022)]. Available online: https://www.g-ba.de/richtlinien/84.

Kato M., Yamamoto K. Clinical characteristics of elderly patients with aortic stenosis. J. Echocardiogr. 2015;13:134–140. doi: 10.1007/s12574-015-0264-2. PubMed DOI

Lauck S.B., Wood D.A., Baumbusch J., Kwon J.Y., Stub D., Achtem L., Blanke P., Boone R.H., Cheung A., Dvir D., et al. Vancouver Transcatheter Aortic Valve Replacement Clinical Pathway: Minimalist Approach, Standardized Care, and Discharge Criteria to Reduce Length of Stay. Circ. Cardiovasc. Qual. Outcomes. 2016;9:312–321. doi: 10.1161/CIRCOUTCOMES.115.002541. PubMed DOI

Stub D., Lauck S., Lee M., Gao M., Humphries K., Chan A., Cheung A., Cook R., Della Siega A., Leipsic J., et al. Regional Systems of Care to Optimize Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement. JACC Cardiovasc. Interv. 2015;8:1944–1951. doi: 10.1016/j.jcin.2015.09.017. PubMed DOI

Lortz J., Lortz T.P., Johannsen L., Rammos C., Steinmetz M., Lind A., Rassaf T., Jánosi R.A. Clinical process optimization of transfemoral transcatheter aortic valve implantation. Future Cardiol. 2020;17:321–327. doi: 10.2217/fca-2020-0010. PubMed DOI

Hawthorne G., Sansoni J., Hayes L., Marosszeky N., Sansoni E. Measuring patient satisfaction with health care treatment using the Short Assessment of Patient Satisfaction measure delivered superior and robust satisfaction estimates. J. Clin. Epidemiol. 2014;67:527–537. doi: 10.1016/j.jclinepi.2013.12.010. PubMed DOI

Wurschinger F., Wittmann S., Goldfuss S., Zech N., Debl K., Hilker M., Graf B.M., Zausig Y.A. Complications after transcatheter aortic valve implantation using transfemoral and transapical approach in general anaesthesia. PLoS ONE. 2018;13:e0193558. doi: 10.1371/journal.pone.0193558. PubMed DOI PMC

German Heart Center Transcatheter Aortic Valve Implantation. [(accessed on 30 July 2019)]. Available online: https://www.dhm.mhn.de/ww/en/pub/dhm/kliniken_und_institute/herz_und_gefaesschirurgie/chir_erworbene_herzfehler/transcatheter_aortic_valve_imp.htm.

Universitätsklinikum Düsseldorf Universitätsklinikum Düsseldorf-über das UKD. [(accessed on 30 July 2019)]. Available online: https://www.uniklinik-duesseldorf.de/ueber-das-ukd/unternehmen.

Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., Salamon R. European system for cardiac operative risk evaluation (EuroSCORE) Eur. J. Cardiothorac. Surg. 1999;16:9–13. doi: 10.1016/S1010-7940(99)00134-7. PubMed DOI

Roques F., Michel P., Goldstone A.R., Nashef S.A. The logistic EuroSCORE. Eur. Heart J. 2003;24:881–882. doi: 10.1016/S0195-668X(02)00799-6. PubMed DOI

Kjonas D., Dahle G., Schirmer H., Malm S., Eidet J., Aaberge L., Steigen T., Aakhus S., Busund R., Rosner A. Predictors of early mortality after transcatheter aortic valve implantation. Open Heart. 2019;6:e000936. doi: 10.1136/openhrt-2018-000936. PubMed DOI PMC

Afilalo J., Eisenberg M.J., Morin J.F., Bergman H., Monette J., Noiseux N., Perrault L.P., Alexander K.P., Langlois Y., Dendukuri N., et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J. Am. Coll. Cardiol. 2010;56:1668–1676. doi: 10.1016/j.jacc.2010.06.039. PubMed DOI

Chopra M., Luk N.H.V., De Backer O., Søndergaard L. Simplification and optimization of transcatheter aortic valve implantation—fast-track course without compromising safety and efficacy. BMC Cardiovasc. Disord. 2018;18:231. doi: 10.1186/s12872-018-0976-0. PubMed DOI PMC

Forman J.M., Currie L.M., Lauck S.B., Baumbusch J. Exploring changes in functional status while waiting for transcatheter aortic valve implantation. Eur. J. Cardiovasc. Nurs. 2015;14:560–569. doi: 10.1177/1474515114553907. PubMed DOI

Barbanti M., van Mourik M.S., Spence M.S., Icovelli F., Martinelli G.L., Muir D.F., Saia F., Bortone A.S., Densem C.G., van der Kley F., et al. Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: The multicentre European FAST-TAVI trial. EuroIntervention. 2019;15:147–154. doi: 10.4244/EIJ-D-18-01197. PubMed DOI

Veulemans V., Piayda K., Afzal S., Polzin A., Quast C., Jung C., Westenfeld R., Zeus T., Kelm M., Hellhammer K. Cost-comparison of third generation transcatheter aortic valve implantation (TAVI) devices in the German Health Care System. Int. J. Cardiol. 2019;278:40–45. doi: 10.1016/j.ijcard.2018.12.007. PubMed DOI

Sangaraju S., Cox I., Dalrymple-Hay M., Lloyd C., Suresh V., Riches T., Melhuish S., Asopa S., Newcombe S., Deutsch C., et al. Effect of procedural refinement of transfemoral transcatheter aortic valve implantation on outcomes and costs: A single-centre retrospective study. Open Heart. 2019;6:e001064. doi: 10.1136/openhrt-2019-001064. PubMed DOI PMC

Droppa M., Borst O., Katzenberger T., Krause R., Bramlage K., Bramlage P., Lausberg H.F., Schlensak C., Grasshoff C., Gawaz M., et al. Clinical and Economical impact of the presence of an extended heart team throughout the balloon-expandable transcatheter aortic valve implantation procedure. Clin. Res. Cardiol. 2019;108:315–323. doi: 10.1007/s00392-018-1359-3. PubMed DOI

Olsson K., Naslund U., Nilsson J., Hornsten A. Experiences of and Coping With Severe Aortic Stenosis Among Patients Waiting for Transcatheter Aortic Valve Implantation. J. Cardiovasc. Nurs. 2016;31:255–261. doi: 10.1097/JCN.0000000000000231. PubMed DOI

Baumbusch J., Lauck S.B., Achtem L., O'Shea T., Wu S., Banner D. Understanding experiences of undergoing transcatheter aortic valve implantation: One-year follow-up. Eur. J. Cardiovasc. Nurs. 2018;17:280–288. doi: 10.1177/1474515117738991. PubMed DOI

Hawkey M.C., Lauck S.B., Perpetua E.M., Fowler J., Schnell S., Speight M., Lisby K.H., Webb J.G., Leon M.B. Transcatheter aortic valve replacement program development: Recommendations for best practice. Catheter. Cardiovasc. Interv. 2014;84:859–867. doi: 10.1002/ccd.25529. PubMed DOI

Tchetche D., de Biase C., Brochado B., Mastrokostopoulos A. How to Make the TAVI Pathway More Efficient. Interv. Cardiol. 2019;14:31–33. doi: 10.15420/icr.2018.28.2. PubMed DOI PMC

De Ronde-Tillmans M., Goudzwaard J.A., El Faquir N., van Mieghem N.M., Mattace-Raso F.U.S., Cummins P.A., Lenzen M.J., de Jaegere P.P.T. TAVI Care and Cure, the Rotterdam multidisciplinary program for patients undergoing transcatheter aortic valve implantation: Design and rationale. Int. J. Cardiol. 2020;302:36–41. doi: 10.1016/j.ijcard.2019.12.005. PubMed DOI

Folstein M.F., Folstein S.E., White T., Messer M.A. Mini-Mental State Examination. Psychological Assessment Resources; Lutz, FL, USA: 2010.

McCalmont G., Durand E., Lauck S., Muir D.F., Spence M.S., Vasa-Nicotera M., Wood D., Saia F., Chatel N., Lüske C.M., et al. Setting a benchmark for resource utilization and quality of care in patients undergoing transcatheter aortic valve implantation in Europe—Rationale and design of the international BENCHMARK registry. Clin. Cardiol. 2021;44:1344–1353. doi: 10.1002/clc.23711. PubMed DOI PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...